What are Hypertrophic Scar?
Hypertrophic Scars are raised, red, rigid, inflexible cell-like, and cosmetic problems precipitated due to multiple underlying dermal injuries such as burn, surgery, and trauma during which aberrant wound healing with more pathological deposition of the extracellular matrix than degradation leads to their spawning.
How Hypertrophic Scar affected population?
Hypertrophic Scar Epidemiology –
- Females and males have equal risk of developing Hypertrophic Scar.
- Adolescents and pregnant women may have a greater probability of forming Hypertrophic Scar.
- Incidence rates of Hypertrophic Scar have been reported as high as 91% following extensive trauma, such as a deep burn injury, suggesting a role for the extent of trauma in their development.
Hypertrophic Scar Market Outlook
According to DelveInsight, Hypertrophic Scar market in 7MM is expected to change in the study period 2017-2030. The key driver for the surge in Hypertrophic Scar market size is the rise in number of incident/prevalent cases.
Neodyne Biosciences’ Embrace Advanced Scar Therapy System has been approved by the FDA top treat HTSs. It delivers mechano-modulation therapy to the injury site and surrounding tissues. The device includes a simple disposable applicator that transfers a predetermined level of strain to a single use adhesive silicone sheet, which is then adhered over the closed scar. This unique mechanism of action provides a uniform compressive strain, or stress-shield around a closed scar, which can minimize collagen proliferation and formation of scar tissue. The Embrace device was cleared by the FDA in September 2011 and is the only FDA-Cleared scar therapy system designed to relieve tension around incisions, general cuts and lacerations to prevent the formation of new, visible, raised scars before they start.
The Hypertrophic Scar market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Hypertrophic Scar market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
To know more, request sample pages @Hypertrophic Scar Market Landscape
Which are the leading companies in Hypertrophic Scar market?
The pipeline of Hypertrophic scars is quiet weak with few potential key players, such as Henry Ford Health System/ Gladerma, Phio Pharmaceuticals and others. The dynamics of HTS market is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise of efficient treatment options. The launch of emerging therapies is expected during the forecast period of 2020–2030.
Request sample pages for more information on Hypertrophic Scar Market Report
Table of contents
1. Key Insights
2. Executive Summary of Hypertrophic Scar
3. Competitive Intelligence Analysis for Hypertrophic Scar
4. Hypertrophic Scar: Market Overview at a Glance
4.1. Hypertrophic Scar Total Market Share (%) Distribution in 2017
4.2. Hypertrophic Scar Total Market Share (%) Distribution in 2030
5. Hypertrophic Scar: Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Hypertrophic Scar Patient Journey
7. Hypertrophic Scar Epidemiology and Patient Population
7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
7.3.1. Hypertrophic Scar Epidemiology Scenario in the 7MM (2017-2030)
7.4. United States Epidemiology
7.4.1. Hypertrophic Scar Epidemiology Scenario in the United States (2017-2030)
7.5. EU-5 Country-wise Epidemiology
7.5.1. Germany Epidemiology
7.5.1.1. Hypertrophic Scar Epidemiology Scenario in Germany (2017-2030)
7.5.2. France Epidemiology
7.5.2.1. Hypertrophic Scar Epidemiology Scenario in France (2017-2030)
7.5.3. Italy Epidemiology
7.5.3.1. Hypertrophic Scar Epidemiology Scenario in Italy (2017-2030)
7.5.4. Spain Epidemiology
7.5.4.1. Hypertrophic Scar Epidemiology Scenario in Spain (2017-2030)
7.5.5. United Kingdom Epidemiology
7.5.5.1. Hypertrophic Scar Epidemiology Scenario in the United Kingdom (2017-2030)
7.5.6. Japan Epidemiology
7.5.6.1. Hypertrophic Scar Epidemiology Scenario in Japan (2017-2030)
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Hypertrophic Scar Treatment and Management
8.2. Hypertrophic Scar Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Hypertrophic Scar Treatment
11. Marketed Products
11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
11.2.1. Product Description
11.2.2. Regulatory Milestones
11.2.3. Other Developmental Activities
11.2.4. Pivotal Clinical Trials
11.2.5. Summary of Pivotal Clinical Trial
List to be continued in report
12. Emerging Therapies
12.1. Key Cross
12.2. Drug Name: Company Name
12.2.1. Product Description
12.2.2. Other Developmental Activities
12.2.3. Clinical Development
12.2.4. Safety and Efficacy
12.2.5. Product Profile
List to be continued in report
13. Hypertrophic Scar: Seven Major Market Analysis
13.1. Key Findings
13.2. Hypertrophic Scar Market Size in 7MM
13.3. Hypertrophic Scar Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
15.1. United States: Market Size
15.1.1. Hypertrophic Scar Total Market Size in the United States
15.1.2. Hypertrophic Scar Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
15.3.1. Hypertrophic Scar Total Market Size in Germany
15.3.2. Hypertrophic Scar Market Size by Therapies in Germany
15.4. France Market Size
15.4.1. Hypertrophic Scar Total Market Size in France
15.4.2. Hypertrophic Scar Market Size by Therapies in France
15.5. Italy Market Size
15.5.1. Hypertrophic Scar Total Market Size in Italy
15.5.2. Hypertrophic Scar Market Size by Therapies in Italy
15.6. Spain Market Size
15.6.1. Hypertrophic Scar Total Market Size in Spain
15.6.2. Hypertrophic Scar Market Size by Therapies in Spain
15.7. United Kingdom Market Size
15.7.1. Hypertrophic Scar Total Market Size in the United Kingdom
15.7.2. Hypertrophic Scar Market Size by Therapies in the United Kingdom
15.8. Japan Market Outlook
15.8.1. Japan Market Size
15.8.2. Hypertrophic Scar Total Market Size in Japan
15.8.3. Hypertrophic Scar Market Size by Therapies in Japan
16. Access and Reimbursement Overview of Hypertrophic Scar
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
*The table of contents is not exhaustive; the final content may vary.
Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/